Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries

Clinical Endocrinology

Volumn 44, Issue 3, 1996, Pages 277-284

  Robinson, S ^a   Henderson, A D ^a   Gelding, S V ^a   Kiddy, D ^a   Niththyananthan, R ^a   Bush, A ^a   Richmond, W ^a   Johnston, D G ^a   Franks, S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN;

ADULT; ARTICLE; COMPLICATION; CONTROLLED STUDY; DIAGNOSIS; DYSLIPIDEMIA; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0030040101     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.674495.x     Document Type: Article

References (28)

1. Adams, J., Polson, D.W. & Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. British Medical Journal, 293, 355-359.
2. Akinmokun, A., Selby, P.L., Ramaiya, K. & Alberti, K.G.M.M. (1992) The short insulin toleranee test for determination of insulin sensitivity. Diabetic Medicine, 9, 432-437.
3. Bonora, E., Moghetti, P., Zancanaro, C., Cigolini, M., Querena, M., Cacciatori, V., Corgnati, A. & Muggeo, M. (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycaemic and hyperglycaemic glucose clamp studies. Journal of Clinical Endocrinology and Metabolism, 68, 374-378.
4. Burghen, G.A., Givens, J.R. & Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 50, 113-116.
5. Chang, R.J., Nakamura, R.M., Judd, H.L. & Kaplan, S.L. (1983) Insulin resistance in nonobese patients with polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 57, 356-359.
6. Conway, G.S., Agrawal, R. Betteridge, D.J. & Jacobs, H.S. (1992) Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clinical Endocrinology, 37, 119-125.
7. Conway, G.S., Clark, P.M.S. & Wong, D. (1993) Hyperinsulinaemia in the polcystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clinical Endocrinology, 38, 219-222.
8. Dahlgren, E., Janson, P.O., Johansson, S., Mattsom, L.-A., Lindstedt, G., Crona, N, Kuntsson, F, Lundberg, P.-A. & Oden, A. (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow up focusing on natural history and circulating hormones. Fertility and Sterility, 57, 505-513.
9. Dunaif, A., Graf, M., Mandeli, J., Laumas, V. & Dobrjansky, A. (1987) Characterisation of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinaemia. Journal of Clinical Endocrinology and Metabolism, 65, 449-507.
10. Dunaif, A., Segal, K.R., Futterweit, W. & Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174.
11. Friedewald, W.T., Levy, R.I. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentifuge. Clinical Chemistry, 18, 499-502.
12. Gelding, S.V., Robinson, S., Lowe, S., Niththyananthan, R. & Johnston, D.G. (1994) Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clinical Endocrinology, 40, 611-615.
13. Graf, M.J., Richards, C.J., Brown, V., Meissner, L. & Dunaif, A. (1990) The independent effects of hyperandrogenaemia, hyperinsulinaemia, and obesity on lipid and lipoprotein profiles in women. Clinical Endocrinology, 33, 119-131.
14. Hampton, S.M. & Marks, V. (1979) Development, validation and use of a human C-peptide radioimmunoassay. Diabetologia, 17, 24.
15. Holte, J., Bergh, T., Berne, C. & Lithell, H. (1994) Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Clinical Endocrinology, 41, 463-471.
16. Jialal, I., Naiker, P., Reddi, K., Moodley, J. & Joubert, S.M. (1987) Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 64, 1066-1069.
17. Kiddy, S.D., Sharp, P.S., White, D.M., Scanlon, M.F., Mason, H.D., Bray, C.S., Polson, D.W., Reed, M.J. & Franks, S. (1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clinical Endocrinology, 32, 213-220.
18. Mahabeer, S., Jialal, I., Norman, R.J., Naidoo, C., Reddi, K. & Joubert, S.M. (1989) Insulin and C-Peptide secretion in non-obese patients with polycystic ovarian disease. Hormone and Metabolic Research, 21, 502-506.
19. Mattsson, L.-A., Cullberg, G., Hamberger, L., Samsioe, G. & Silfverstolpe, G. (1984) Lipid metabolism in women with polycystic ovary syndrome: possible implications for increased risk of coronary heart disease. Fertility and Sterility, 42, 579-584.
20. Pasquali, R., Antenucci, D., Casimirri, F., Venturoli, S., Paradisi, R., Fabbri, R., Balestra, V., Melchionda, N. & Barabara, L. (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. Journal of Clinical Endocrinology and Metabolism, 68, 173-179.
21. Pasquali, R., Venturoli, S., Paradis, R., Capelli, M., Parenti, M. & Melchionda, N. (1982) Insulin and C-peptide levels in obese patients with polycystic ovaries. Hormone and Metabolic Research, 154, 284-287.
22. Robinson, S., Chan, S.-P., Spacey, S., Anyaoku, V., Johnslon, D.G. & Franks, S. (1992) Postprandial thermogenesis is reduced in polycystic ovary syndrome and is associated with increased insulin resistance. Clinical Endocrinology, 36, 537-543.
23. Robinson, S., Kiddy, D., Gelding, S.V., Willis, D., Niththyananthan, R., Bush, A., Johnston, D.G. & Franks, S. (1993) The relationship of insulin sensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clinical Endocrinology, 39, 351-355.
24. Sharp, P.S., Kiddy, D.S., Reed, M.J., Anyaoku, V., Johnston, D.G. & Franks, S. (1991) Correlation of plasma insulin and insulin like growth factor-1 with indices of androgen transport and metabolism in women with polycystic ovary syndrome. Clinical Endocrinology, 35, 253-257.
25. Shoupe, D., Kumar, D.D. & Lobo, R.A. (1983) Insulin resistance in polycystic ovary syndrome. American Journal of Obstetrics and Gynecology, 147, 588-592.
26. Warnick, G.R., Benderson, J. & Albers, J.J. (1982) Dextran sulphate-Mg2+ precipitation procedure for quantification of high density lipoprotein cholesterol. Clinical Chemistry, 28, 1379-88.
27. Wild, R.A. & Bartholomew, M.J. (1988) The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome. American Journal of Obstetrics and Gynecology, 159, 423-427.
28. Wild, R.A., Painter, P.C., Coulson, P.B., Carruth, K.B. & Ranny, G.B. (1985) Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 61, 946-951.